1. Roles of purinergic P2X 7 receptor in glioma and microglia in brain tumors
   James G. McLarnon, 2017, Cancer Letters CrossRef
2. Fabrication of adenosine 5′-triphosphate-capped silver nanoparticles: Enhanced cytotoxicity efficacy and targeting effect against tumor cells
   Toktam Rajabnia et al, 2017, Process Biochemistry CrossRef
3. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives
   Paola de Andrade Mello et al, 2017, Front. Immunol. CrossRef
4. Involvement of P2X₇ Receptor in Proliferation and Migration of Human Glioma Cells.
   Zhenhua Ji et al, 2018, Biomed Res Int CrossRef
5. The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
   Luiz E. B. Savio et al, 2018, Front. Pharmacol. CrossRef
6. ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
   SM Gilbert et al, 2018, Oncogene CrossRef
7. Ethanol upregulates the P2X7 purinergic receptor in human macrophages
   Brendan Le Daré et al, 2018, Fundam Clin Pharmacol CrossRef
8. High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer
   Fei Qian et al, 2017, Human Pathology CrossRef
9. Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers.
   Zhengfeng Yang et al, 2020, Front Oncol CrossRef
10. Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca2+ signal
    Abdallah Mound et al, 2017, Oncotarget CrossRef
11. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
    Romain Lara et al, 2020, Front. Pharmacol. CrossRef
12. Calcium signaling: breast cancer’s approach to manipulation of cellular circuitry
    Stephen JP Pratt et al, 2020, Biophys Rev CrossRef
13. P2X7 receptor: a critical regulator and potential target for breast cancer
    Xiaodi Zhu et al, 2021, J Mol Med CrossRef
14. Targeting the purinergic pathway in breast cancer and its therapeutic applications
    Julia Beatrice de Araújo et al, 2021, Purinergic Signalling CrossRef
15. To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question
    Serena Janho dit Hreich et al, 2021, Purinergic Signalling CrossRef
16. Estrogen receptor β alleviates inflammatory lesions in a rat model of inflammatory bowel disease via down-regulating P2X7R expression in macrophages
    Qian Jiang et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef
17. Purinergic signaling: Diverse effects and therapeutic potential in cancer
    Jasmeet Kaur et al, 2023, Front. Oncol. CrossRef
18. P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways
    Xue Bai et al, 2023, Purinergic Signalling CrossRef
19. Purinergic P2X7R as a potential target for pancreatic cancer
    Qingqing Yu et al, 2023, Clin Transl Oncol CrossRef
20. The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers
    Xin Wang et al, 2023 CrossRef
21. P2X7 receptors: a bibliometric review from 2002 to 2023
    Haiting Tang et al, 2024, Purinergic Signalling CrossRef
22. Novel synthesized ionizable lipid for LNP-mediated P2X7siRNA to inhibit migration and induce apoptosis of breast cancer cells
    Seyed Hossein Kiaie et al, 2024, Purinergic Signalling CrossRef
23. Role of the P2X7 receptor in breast cancer progression
    Yanan Du et al, 2024, Purinergic Signalling CrossRef
24. Unraveling the role of the P2X7 receptor in cancer radioresistance: Molecular insights and therapeutic implications
    Seyedeh Nasibeh Mousavikia et al, 2025, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef